esketamine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The substantive delay (often 4–6 weeks) between the commencement of an antidepressant and any discernible improvement in…
Abstract Maju et al. provided clarifications on important and controversial issues related to esketamine clinical trial data, in…
Since the FDA approved intranasal esketamine, there has understandably been significant dialogue, debate, and discussion about…
An advisory committee to the US Food and Drug Administration (FDA) has strongly endorsed esketamine, a derivative of the…
Ketamine, an NMDA receptor antagonist with efficacy as a rapid anti-depressant, has early evidence for action to reduce suicidal…
Clinical trial failures of two drugs for hearing loss and tinnitus underscore pitfalls for a nascent area of drug development…
Pivotal trials of Alkermes's antidepressant ALKS 5461 show how a patented clinical trial design might be able to help control…
OBJECTIVE
The pathogenesis and etiology of still remain unknown. Current evidence suggests that the occurrence of depression may…
OBJECTIVES
The study was undertaken to compare different anaesthetic techniques for scheduled or urgent caesarean section with…